"T-Lymphocytes" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen.
Descriptor ID |
D013601
|
MeSH Number(s) |
A11.118.637.555.567.569 A15.145.229.637.555.567.569 A15.382.490.555.567.569
|
Concept/Terms |
T-Lymphocytes- T-Lymphocytes
- T Lymphocytes
- T-Lymphocyte
- T-Cells
- T Cells
- T-Cell
- Thymus-Dependent Lymphocytes
- Lymphocyte, Thymus-Dependent
- Lymphocytes, Thymus-Dependent
- Thymus Dependent Lymphocytes
- Thymus-Dependent Lymphocyte
|
Below are MeSH descriptors whose meaning is more general than "T-Lymphocytes".
Below are MeSH descriptors whose meaning is more specific than "T-Lymphocytes".
This graph shows the total number of publications written about "T-Lymphocytes" by people in this website by year, and whether "T-Lymphocytes" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 13 | 13 | 26 |
1995 | 20 | 15 | 35 |
1996 | 18 | 7 | 25 |
1997 | 21 | 11 | 32 |
1998 | 22 | 14 | 36 |
1999 | 16 | 13 | 29 |
2000 | 23 | 15 | 38 |
2001 | 17 | 13 | 30 |
2002 | 26 | 17 | 43 |
2003 | 32 | 24 | 56 |
2004 | 32 | 24 | 56 |
2005 | 37 | 32 | 69 |
2006 | 42 | 25 | 67 |
2007 | 39 | 39 | 78 |
2008 | 32 | 30 | 62 |
2009 | 33 | 22 | 55 |
2010 | 32 | 32 | 64 |
2011 | 38 | 31 | 69 |
2012 | 40 | 25 | 65 |
2013 | 32 | 24 | 56 |
2014 | 35 | 8 | 43 |
2015 | 46 | 19 | 65 |
2016 | 34 | 25 | 59 |
2017 | 49 | 44 | 93 |
2018 | 50 | 22 | 72 |
2019 | 37 | 29 | 66 |
2020 | 51 | 34 | 85 |
2021 | 36 | 54 | 90 |
2022 | 13 | 45 | 58 |
2023 | 12 | 69 | 81 |
2024 | 1 | 17 | 18 |
To return to the timeline,
click here.
Below are the most recent publications written about "T-Lymphocytes" by people in Profiles.
-
T-cell dysfunctions in myelodysplastic syndromes. Blood. 2024 Apr 04; 143(14):1329-1343.
-
Let-7i enhances anti-tumour immunity and suppresses ovarian tumour growth. Cancer Immunol Immunother. 2024 Mar 30; 73(5):80.
-
Secondary bone marrow graft loss after third-party virus-specific T cell infusion: Case report of a rare complication. Nat Commun. 2024 Mar 29; 15(1):2749.
-
Antitumor efficacy and safety of unedited autologous CD5.CAR T cells in relapsed/refractory mature T-cell lymphomas. Blood. 2024 Mar 28; 143(13):1231-1241.
-
DNAJB1-PRKACA fusion neoantigens elicit rare endogenous T?cell responses that potentiate cell therapy for fibrolamellar carcinoma. Cell Rep Med. 2024 Mar 19; 5(3):101469.
-
BTN1A1 is a novel immune checkpoint mutually exclusive to PD-L1. J Immunother Cancer. 2024 Mar 14; 12(3).
-
Durable immunity to EBV after rituximab and third-party LMP-specific T cells: a Children's Oncology Group study. Blood Adv. 2024 Mar 12; 8(5):1116-1127.
-
Autophagy differentially regulates tissue tolerance of distinct target organs in graft-versus-host disease models. J Clin Invest. 2024 Mar 01; 134(5).
-
A novel lentiviral vector-based approach to generate chimeric antigen receptor T cells targeting Aspergillus fumigatus. mBio. 2024 Apr 10; 15(4):e0341323.
-
Nanofibrous MultiDomain Peptide Hydrogels Provide T Cells a 3D, Cytocompatible Environment for Cell Expansion and Antigen-Specific Killing. ACS Biomater Sci Eng. 2024 Mar 11; 10(3):1448-1460.